Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

BioImpacts, an esteemed journal published by Tabriz University of Medical Sciences & Health Services, is a prominent platform dedicated to advancing the fields of Biochemistry, Genetics, Molecular Biology, Medicine, and Pharmaceutical Science. Established in 2011, this Open Access journal ensures that vital research findings are freely accessible to the global academic community. With an impressive presence in the Scopus database, BioImpacts currently holds a Q2 quartile ranking in its respective categories, reflecting its contribution to scientific discourse and its importance as a critical resource for researchers and practitioners alike. The journal's dynamic scope encompasses a wide range of topics, highlighting innovative research that addresses contemporary challenges in health and disease. Operating out of Tabriz, Iran, BioImpacts is committed to fostering interdisciplinary collaboration and knowledge dissemination through their dedicated publication efforts, which span from 2011 to 2024. Researchers, professionals, and students are encouraged to explore the rich content and cutting-edge studies presented in this journal, making it an indispensable resource in the scientific community.

Infectious Diseases and Clinical Microbiology is a pivotal journal dedicated to advancing our understanding of infectious diseases through rigorous scientific research and clinical practices. Published by DOC DESIGN INFORMATICS CO LTD, this journal serves as a vital platform for researchers, healthcare professionals, and students keen on enhancing their knowledge of microbiological sciences and the clinical implications of infectious agents. With an ISSN of 2667-646X, it aims to disseminate significant findings in the field, enriching the scholarly dialogue surrounding infectious diseases. While currently operating under a traditional access model, the journal encourages global collaboration and knowledge sharing, striving to make a meaningful impact in tackling the challenges posed by infectious diseases. Its content aims to bridge the gap between laboratory research and clinical application, making it an essential resource in the contemporary landscape of global health.

CURRENT MICROBIOLOGY, published by SPRINGER, is a renowned journal that serves as a critical platform for the dissemination of cutting-edge research in the field of microbiology. With an ISSN of 0343-8651 and an E-ISSN of 1432-0991, this journal contributes significantly to the scientific community by covering a diverse range of topics from applied microbiology and biotechnology to various aspects of medicine. Currently operating an impact factor that places it within the Q2 quartile in both applied microbiology and biotechnology and medicine (miscellaneous), along with a Q3 ranking in microbiology, CURRENT MICROBIOLOGY is recognized for its valuable contributions to these dynamic fields. This journal, which has documented the evolution of microbiological research since its inception in 1978, provides an essential venue for researchers, professionals, and students alike to explore innovative studies and advances. Although it does not offer open access, the journal remains a pivotal resource within its category, complementing the ongoing growth and exploration of microbiology from its headquarters at One New York Plaza, Suite 4600, New York, NY 10004, United States. Its Scopus rankings highlight its reputable standing, making it a key publication for anyone aiming to stay at the forefront of microbiological science.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, published by Elsevier Science Inc, is a leading journal in the fields of Infectious Diseases, Microbiology, and Medicine. Since its inception in 1983, this esteemed journal has consistently provided a platform for original research and comprehensive reviews that advance the understanding of diagnostic microbiology and its implications for infectious diseases. With an impressive impact factor placing it in the Q2 category in multiple relevant fields as of 2023, it stands out with Scopus rankings reinforcing its significance in academia, ranking #136 out of 344 in Infectious Diseases and #64 out of 140 in Medical Microbiology. This journal is essential for researchers, healthcare professionals, and students who seek to stay abreast of the latest developments and trends in infectious diagnostics. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE is committed to fostering excellence in research quality and academic rigor, ensuring accessibility to vital knowledge for addressing some of the most pressing health challenges of our time.

Indonesian Biomedical Journal, published by PRODIA EDUCATION & RESEARCH INST, serves as a vital platform for the dissemination of groundbreaking research in the fields of biochemistry, genetics, and molecular biology, as well as general medicine. Since its inception, this Open Access journal has made significant strides in enhancing accessibility to scientific knowledge, allowing researchers, professionals, and students to engage with high-quality studies without financial barriers. With an ISSN of 2355-9179 and a focus on emerging biomedical topics, the journal has established itself in the academic community, securing Q3 and Q4 rankings in its respective categories for 2023. The journal's commitment to maintaining a rigorous peer-review process ensures that only the most innovative and impactful research is published, fostering an environment that encourages collaborative learning and discovery. As it converges from 2017 to 2024, the Indonesian Biomedical Journal continues to be an essential resource for those involved in advancing biomedical sciences, particularly within the unique context of Indonesia and beyond.

International Journal of Biomedicine, published by INT MEDICAL RESEARCH & DEVELOPMENT CORP, is a premier Open Access journal dedicated to advancing knowledge in the multifaceted fields of biomedicine, including but not limited to biochemistry, genetics, immunology, microbiology, and neuroscience. With its ISSN 2158-0510 and E-ISSN 2158-0529, this journal has been serving as a significant platform for researchers since its inception in 2011, ensuring the dissemination of high-quality, peer-reviewed articles. Despite currently holding a Q4 ranking in prominent categories such as Biochemistry, Genetics and Molecular Biology and Neuroscience, the journal plays a vital role in fostering scientific dialogue and innovation in these rapidly evolving domains. The journal's commitment to accessibility further empowers both seasoned professionals and budding scholars to contribute to, and benefit from, the wealth of research that characterizes the biomedicine landscape. With a significant emphasis on interdisciplinary approaches and contemporary issues, the International Journal of Biomedicine is an essential resource for those aiming to navigate the complex intersections of health, disease, and biomedical discovery.

BMC Research Notes, published by SPRINGERNATURE, is a leading open-access journal dedicated to the dissemination of research notes across various disciplines, particularly within the fields of biochemistry, genetics, molecular biology, and medicine. Since its establishment in 2008, the journal has embraced a mission to facilitate the rapid publication of short, concise articles that contribute significantly to ongoing scientific dialogues. With an impact factor reflective of its reputation, BMC Research Notes ranks Q2 in Biochemistry, Genetics and Molecular Biology and holds a commendable Q3 classification in Medicine for 2023. Notably, the journal's Scopus rankings highlight its prominence, especially in General Medicine, where it stands in the 77th percentile. Situated in the United Kingdom, the journal prioritizes open access to foster transparency and engagement with a global audience, making it an essential resource for researchers, practitioners, and students who are looking to stay abreast of new findings and practical advancements within their fields. The journal continues to span evolving research themes from 2008 to 2024, ensuring a dynamic repository of knowledge in the rapidly advancing landscape of biomedical research.

Clinical Infectious Diseases, published by Oxford University Press Inc, is a premier journal in the fields of infectious diseases and microbiology, distinguished by its esteemed Q1 ranking in both categories as of 2023. Since its inception, the journal has served as a vital platform for disseminating cutting-edge research and significant advancements in the diagnosis, treatment, and prevention of infectious diseases. With a broad scope encompassing clinical trials, epidemiological studies, and public health research, it targets a diverse readership, including researchers, healthcare professionals, and students. The journal's robust reputation is underscored by its impactful contributions to scientific understanding, making it a critical resource for those striving to combat infectious diseases globally. Clinical Infectious Diseases is not open access but offers various subscription options, ensuring comprehensive access to its high-quality content. With a historical continuity from 1985 to present, the journal remains at the forefront of medical research, paving the way for future innovations in the field.

Biomedica is a distinguished journal published by the Instituto Nacional de Salud in Colombia, dedicated to advancing knowledge within the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 1981, this Open Access journal has embodied a commitment to disseminating high-quality research, ensuring free and universal access to its published works. With an impressive Scopus Ranking—273rd out of 636 in Medicine and 148th out of 221 in Biochemistry, Genetics and Molecular Biology—Biomedica holds a Q3 category in both disciplines as of 2023, reflecting its growing impact and relevance in the scientific community. The journal welcomes contributions that further our understanding and lead to advancements in healthcare and biological sciences, serving as a critical resource for researchers, professionals, and students alike. The journal operates within a continuous publication model from 2001 to 2024, enriching the academic landscape with contemporary findings and fostering collaboration within the biomedical field.